33.64BUSD
Type
Common Stock
Exchange
OTCGREY
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
NL0010832176
CUSIP
04016X101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
43.18
PEG Ratio
-
Book Value
90.49
Dividend Share
-
Dividend Yield
-
Earnings Share
12.76
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
2,248,205,056
Gross Profit TTM
1,037,492,992
EBITDA
-16,323,000
Profit Margin
37.05%
Return On Assets TTM
-0.21%
Return On Equity TTM
17.36%
Revenue Per Share TTM
37.56
Qtly Revenue Growth YOY
81.30%
Diluted Eps TTM
12.76
Qtly Earnings Growth YOY
0.00%
Trailing PE
43.18
Forward PE
100
Price Sales TTM
12.7282
Price Book MRQ
7.745
Enterprise Value Revenue
15
Enterprise Value EBITDA
324
173.71
15.27%575.63
9.16%269.00
7.09%97.17
4.66%438.80
3.26%561.00
2.11%86.71
0.98%233.30
0.63%76.82
0.07%147.49
-2.78%